MedPath

Clinical application of Bailing tablet in chronic obstructive pulmonary disease

Phase 4
Conditions
chronic obstructive pulmonary disease (COPD)
Registration Number
ITMCTR2100005185
Lead Sponsor
Huzhou Hospital of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Meet the diagnostic criteria for chronic obstructive pulmonary disease, and TCM syndrome differentiation belongs to the lung and kidney deficiency type;
2. Aged 45-80 years;
3. Voluntarily participate in clinical research and sign the informed consent;
4. Outpatients.

Exclusion Criteria

1. Combined with more serious primary diseases such as heart, kidney, liver, brain, hematopoietic system;
2. Pregnant or lactating patients;
3. Those who cannot cooperate and have severe cognitive impairment;
4. History of glucocorticoid or p-receptor agonist use within the past 1 month;
5. Patients with contraindications to the study drug.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ung function;TCM syndrome integral;
Secondary Outcome Measures
NameTimeMethod
St. George's respiratory questionnaire;
© Copyright 2025. All Rights Reserved by MedPath